Persistence and adherence to levodopa adjunct medications in elderly patients with Parkinson's disease: a retrospective cohort study using a Japanese claims database
database[Title] 2025-04-26
Summary:
CONCLUSION: More than half of the new anti-PD drugs added to levodopa were discontinued within 1 year, and adherence to treatment, as assessed by filling records, was extremely high in patients with PD, including the elderly population.